Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis

References

• Ogihara T, Kikuchi K, Matsuoka H, et al. Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3–107
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–387
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20 (Erratum in: JAMA 2014;311:1809)
   PubMed Web of Science ®Google Scholar
• McManus RJ, Caulfield M, Williams B; National Institute for Health and Clinical Excellence. NICE hypertension guideline 2011: evidence based evolution. BMJ 2012;344:e181
   PubMed Web of Science ®Google Scholar
• Sato N, Saijo Y, Sasagawa Y, et al; CAMUI Investigators. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year. J Hypertens 2013;31:1245–55
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895–905
   PubMed Web of Science ®Google Scholar
• Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension 2008;52:1045–50
   PubMed Web of Science ®Google Scholar
• Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010;375:906–15
   PubMed Web of Science ®Google Scholar
• Matsui Y, O’Rourke MF, Hoshide S, et al. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012;59:1132–8
   PubMed Web of Science ®Google Scholar
• Sega R, Cesana G, Bombelli M, et al. Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens 1998;16:1585–92
   Google Scholar
• Modesti PA, Morabito M, Bertolozzi I, et al. Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension 2006;47:155–61
   PubMed Web of Science ®Google Scholar
• Sato N, Saijo Y, Hasebe N; CAMUI Investigators. Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) trial: rationale and design. Int Heart J 2012;53:244–8
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, et al.; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417–28
   PubMed Web of Science ®Google Scholar
• Bakris GL, Sarafidis PA, Weir MR, et al; ACCOMPLISH Trial Investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010;375:1173–81
   PubMed Web of Science ®Google Scholar
• Bakris GL, Toto RD, McCullough PA, et al; GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 2008;73:1303–9
   PubMed Web of Science ®Google Scholar
• Loutzenhiser RD, Epstein M, Fischetti F, Horton C. Effects of amlodipine on renal hemodynamics. Am J Cardiol 1989;64:122I–7I; discussion 127I–8I
   PubMed Web of Science ®Google Scholar
• Hayashi K, Ozawa Y, Fujiwara K, et al. Role of actions of calcium antagonists on efferent arteries—with special references to glomerular hypertension. Am J Nephrol 2003;23:229–44
   PubMed Web of Science ®Google Scholar
• Iino Y, Hayashi M, Kawamura T, et al; Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators. Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension—a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive (JLIGHT) study. Hypertens Res 2004;27:21–30
   PubMed Web of Science ®Google Scholar
• Puig JG, Marre M, Kokot F, et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. Am J Hypertens 2007;20:90–7
   PubMed Web of Science ®Google Scholar
• Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012;220:155–9
   PubMed Web of Science ®Google Scholar
• Noshad S, Mousavizadeh M, Mozafari M, et al. Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes. J Hum Hypertens 2014;28:37–43
   PubMed Web of Science ®Google Scholar
• Yokota K, Fukuda M, Matsui Y, et al. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013;36:151–7
   PubMed Web of Science ®Google Scholar
• Hoshide S, Yano Y, Shimizu M, et al. Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment? Hypertension Res 2012;35:862–6
   PubMed Web of Science ®Google Scholar
• Brook RD, Weder AB, Rajagopalan S. “Environmental hypertensionology” the effects of environmental factors on blood pressure in clinical practice and research. J Clin Hypertens (Greenwich) 2011;13:836–42
   PubMed Web of Science ®Google Scholar
• Modesti PA, Morabito M, Massetti L, et al. Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension 2013;61:908–14
   PubMed Web of Science ®Google Scholar
• Wada Y, Hamamoto Y, Ikeda H, et al. Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with type 2 diabetes and early nephropathy. Diabet Med 2012;29:506–8
   PubMed Web of Science ®Google Scholar
• Masugata H, Senda S, Inukai M, et al. Seasonal variation in estimated glomerular filtration rate based on serum creatinine levels in hypertensive patients. Tohoku J Exp Med 2011;224:137–42
   PubMed Web of Science ®Google Scholar
• Arjamaa O, Turunen L, Mäkinen T, et al. Blood pressure and hormonal responses to short whole body cold exposure in subjects with high dietary salt intake. Appl Human Sci 1999;18:203–9
   PubMedGoogle Scholar
• Yilmaz R, Akoglu H, Altun B, et al. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients. Eur J Clin Nutr 2012;66:1214–18
   PubMed Web of Science ®Google Scholar